USITC Investigates Chinese Biotech State Support and Pricing

JD Supra Trade Law

Published February 26th, 2026

Detected March 6th, 2026

Summary

The U.S. International Trade Commission (USITC) has launched an investigation into Chinese state support and pricing practices within the biotechnology sector. The investigation aims to assess the impact on U.S. industry competitiveness and market share, with a report due by January 2027.

View original document View source feed page

What changed

The U.S. International Trade Commission (USITC) has initiated a factfinding investigation (Inv. No. 332-610) into Chinese state support and pricing practices in the biotechnology sector, including genomic sequencing, synthetic biology, and active pharmaceutical ingredient manufacturing. This investigation, prompted by a Senate Appropriations Committee report, will assess the degree of subsidization, market overcapacity, and the impact on U.S. industry market share and competitiveness. The USITC expects to publish its findings by January 22, 2027.

Regulated entities and interested parties should note the various deadlines for participation, including requests to appear at the public hearing on May 27-28, 2026, and deadlines for submitting prehearing and posthearing briefs. While this is a factfinding investigation and not an enforcement action with immediate penalties, the findings could inform future trade policy and potential actions. Companies involved in or affected by these practices should consider submitting relevant information to the USITC by the July 17, 2026 deadline.

What to do next

Review the USITC's investigation scope regarding Chinese state support and pricing in biotechnology.
Consider submitting comments or requests to appear at the public hearing by the specified deadlines (May 11, 2026, for hearing requests; May 14, 2026, for prehearing briefs).
Submit any other relevant written submissions by July 17, 2026.

Source document (simplified)

March 5, 2026

USITC Will Investigate State Support and Pricing Practices by Chinese Biotechnology Firms

Lynn Bergeson, Carla Hutton Bergeson & Campbell, P.C. + Follow Contact LinkedIn Facebook X Send Embed

The U.S. International Trade Commission (USITC) announced on February 26, 2026, that it is undertaking a factfinding investigation to examine Chinese state support and pricing practices in the biotechnology sector and assess how these practices may be affecting the market share and competitiveness of the U.S. industry. USITC states that it is instituting this investigation, “ Impact on U.S. Industry of China’s State Support and Pricing Practices in the Biotechnology Sector ” (Inv. No. 332-610), following guidance in a report by the Senate Appropriations Committee accompanying the Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026. The Committee report states that USITC’s report:

Should include detailed information, to the extent practicable, on the degree of subsidization and market overcapacity by Chinese biotechnology firms and its impact on U.S. industry, including genomic sequencing, synthetic biology, and active pharmaceutical ingredient manufacturing;
Should examine the extent to which Chinese state support and pricing practices may be affecting U.S. market share and competitiveness in biotechnology-related products and services; and
Should be transmitted to the House of Representatives and Senate Committees on Appropriations within 12 months of the Act’s enactment.
USITC will hold a public hearing in connection with the investigation on May 27, 2026, and continuing, if necessary, on May 28, 2026. USITC provided the following dates as they relate to its investigation:
May 11, 2026: Deadline for filing requests to appear at the public hearing;
May 14, 2026: Deadline for filing prehearing briefs and statements;
May 20, 2026: Deadline for filing electronic copies of hearing oral statements;
May 27-28, 2026: Public hearing;
June 11, 2026: Deadline for filing posthearing briefs; and
July 17, 2026: Deadline for filing all other written submissions.
USITC expects to publish its report by January 22, 2027.

[View source.]

Send Print Report

Latest Posts

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.
Attorney Advertising.

Written by:

Bergeson & Campbell, P.C. Contact + Follow Lynn Bergeson + Follow Carla Hutton + Follow more less

What do you want from legal thought leadership?

Please take our short survey – your perspective helps to shape how firms create relevant, useful content that addresses your needs:

Take the survey now »

Published In:

Biotechnology + Follow China + Follow Competition + Follow Government Agencies + Follow International Trade + Follow International Trade Commission (ITC) + Follow Life Sciences + Follow Pharmaceutical Industry + Follow Product Pricing + Follow Regulatory Oversight + Follow State Aid + Follow Trade Policy + Follow Trade Relations + Follow US Trade Policies + Follow Health + Follow International Trade + Follow Science, Computers & Technology + Follow more less

Bergeson & Campbell, P.C. on:

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign Up Log in ** By using the service, you signify your acceptance of JD Supra's Privacy Policy.* - hide - hide